The Effects of Cervical Sensorimotor Control Challenges on Gait Patterns, Cervical Sensorimotor Control During Dynamic Tasks

April 7, 2026 updated by: YI-JU TSAI, National Cheng Kung University

Influence of Various Cervical Sensorimotor Control Challenges on Gait Patterns, Cervical Sensorimotor Control, and Dual-Task Performance During Dynamic Gait-related Tasks

To investigate the influence of cervical SMC challenges during gait-related dynamic tasks on all task performance and symptoms in patients with CNP.

Study Overview

Status

Completed

Detailed Description

The goal of this observational study is to learn about the immediate effects of cervical sensorimotor challenges during gait-related dynamic tasks on all task performance and symptoms in patients with CNP .

The main question it aims to answer is:

Does adding sensorimotor challenges in chronic neck pain patient will affect balance and gait performance?

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Taiwan
      • Tainan, Taiwan, Taiwan, 701
        • National Cheng Kung University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients with chronic neck pain are: (1) pain was unilateral or bilateral between the superior nuchal line and 1st thoracic vertebra, (2) neck pain persisting for 3 months and above, and (3) average pain intensity of last pain episode was between 2 and 8 based on the numeric rating scale (NRS).

Description

Inclusion Criteria:

  • Healthy asymptomatic adults will not have any complaints of current pain and impairments of neuromusculoskeletal systems within the last 6 months.
  • For patients with CNP

    • Pain was unilateral or bilateral between the superior nuchal line and 1st thoracic vertebra
    • Neck pain persisting for 3 months and above
    • Average pain intensity of last pain episode was between 2 and 8 based on the numeric rating scale (NRS).

Exclusion criteria:

◾For patients with CNP and healthy asymptomatic adults

  • Acute or the first onset of neck pain
  • Traumatic cause of pain
  • Previous fracture or surgery of the spine
  • Diagnosed cardiopulmonary diseases, for example, chronic obstructive pulmonary disease, pulmonary tuberculosis, asthma, chronic bronchitis, pulmonary emphysema
  • Diagnosed gastrointestinal and abdominal conditions which may interfere daily activities within the past 6 months
  • Medical conditions that may affect balance and study procedures (e.g. neurological diseases, vestibular disorders, malignant tumors)
  • Metabolic diseases such as anemia and diabetes
  • Smoking, plan to pregnant or in pregnancy
  • Psychological disorders (affect questionnaire responses)
  • Unable to walk independently
  • Corrected visual abnormalities or individuals unable to wear contact lenses for vision correction due to the potential interference of wearing VR head-mounted display with glasses.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Idiopathic neck pain group
Pain was unilateral or bilateral between the superior nuchal line and 1st thoracic vertebra; Neck pain persisting for 3 months and above; Average pain intensity of last pain episode was between 2 and 8 based on the numerical rating scale (NRS).
Asymptomatic adult group
Do not have any complaints of current pain and impairments of neuromusculoskeletal systems within the last 6 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spatiotemporal parameter
Time Frame: One day
Gait speed (meter/second)
One day
Spatiotemporal parameter
Time Frame: One day
cadence (steps/minute)
One day
Spatiotemporal parameter
Time Frame: One day
stride length (meter)
One day
Spatiotemporal parameter
Time Frame: One day
stride duration (second)
One day
Spatiotemporal parameter
Time Frame: One day
stance duration (second)
One day
Spatiotemporal parameter
Time Frame: One day
swing duration (second)
One day
Spatiotemporal parameter
Time Frame: One day
stance length (meter)
One day
Spatiotemporal parameter
Time Frame: One day
swing length (meter)
One day
Spatiotemporal parameter
Time Frame: One day
step width (meter)
One day
Head and Cervical Kinematics
Time Frame: One day
Mean, range, maximum, and minimum of the angular displacements (degree)
One day
Head and Cervical Kinematics
Time Frame: One day
Mean and peak angular velocity (m/s) and acceleration (m/^2)
One day
Lower Extremity Kinematics and Kinetics
Time Frame: One day
Maximum, minimum, and range angular displacement (degree of joint angle)
One day
Lower Extremity Kinematics and Kinetics
Time Frame: One day
Mean and peak angular velocity and acceleration (m/^2)
One day
Enter of Mass and Center of Pressure (COM-COP)
Time Frame: One day
A 15-component link-segment model will be used to estimate the location of the total body COM. The center of pressure (COP) data will be derived from the outputs of the AMTI force platform.
One day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 16, 2024

Primary Completion (Actual)

September 30, 2025

Study Completion (Actual)

December 31, 2025

Study Registration Dates

First Submitted

June 19, 2024

First Submitted That Met QC Criteria

August 4, 2024

First Posted (Actual)

August 7, 2024

Study Record Updates

Last Update Posted (Actual)

April 8, 2026

Last Update Submitted That Met QC Criteria

April 7, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe